Multiple sclerosis deep grey matter: The relation between demyelination, neurodegeneration, inflammation and iron

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 12, 2014, Pages 1386-1395

  Haider, Lukas ^a   Simeonidou, Constantina ^b   Steinberger, Günther ^a   Hametner, Simon ^a   Grigoriadis, Nikolaos ^b   Deretzi, Georgia ^b   Kovacs, Gabor G ^c   Kutzelnigg, Alexandra ^a   Lassmann, Hans ^a   Frischer, Josa M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ADULT; AGED; BRAIN; BRAIN CHEMISTRY; CASE CONTROL STUDY; CAUDATE NUCLEUS; CHEMISTRY; DEMYELINATING DISEASE; DISEASE COURSE; FEMALE; GRAY MATTER; HUMAN; HYPOTHALAMUS; INFLAMMATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATHOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; GRAY MATTER; HUMANS; HYPOTHALAMUS; INFLAMMATION; IRON; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; WHITE MATTER;

EID: 84939878706     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-307712     Document Type: Article

References (43)

1. Bo L, Vedeler CA, Nyland H, et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003;9:323-31.
2. Kidd D, Barkhof F, McConnell R, et al. Cortical lesions in multiple sclerosis. Brain 1999;122(Pt 1):17-26.
3. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705-12.
4. Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400.
5. Gilmore CP, Donaldson I, Bo L, et al. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 2009;80:182-7.
6. Vercellino M, Plano F, Votta B, et al. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005;64:1101-17.
7. Vercellino M, Masera S, Lorenzatti M, et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009;68:489-502.
8. Fischer MT, Sharma R, Lim JL, et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 2012;135:886-99.
9. Haider L, Fischer MT, Frischer JM, et al. Oxidative damage in multiple sclerosis lesions. Brain 2011;134:1914-24.
10. Mahad D, Lassmann H, Turnbull D. Review: Mitochondria and disease progression in multiple sclerosis. Neuropathol Appl Neurobiol 2008;34:577-89.
11. Hametner S, Wimmer I, Haider L, et al. Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 2013;74:848-61.
12. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41-51.
13. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-11.
14. Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009;132:1175-89.
15. Dal BA, Bradl M, Frischer J, et al. Multiple sclerosis and Alzheimer's disease. Ann Neurol 2008;63:174-83.
16. Bruck W, Porada P, Poser S, et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995;38:788-96.
17. Bakshi R, Czarnecki D, Shaikh ZA, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 2000;11:1153-8.
18. Cifelli A, Arridge M, Jezzard P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650-3.
19. Houtchens MK, Benedict RH, Killiany R, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69:1213-23.
20. Mesaros S, Rovaris M, Pagani E, et al. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol 2008;65:1223-30.
21. Neema M, Arora A, Healy BC, et al. Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging 2009;19:3-8.
22. Wylezinska M, Cifelli A, Jezzard P, et al. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 2003;60:1949-54.
23. Brass SD, Benedict RH, Weinstock-Guttman B, et al. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006;12:437-44.
24. Calabrese M, Rinaldi F, Grossi P, et al. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult Scler 2010;16:1220-8.
25. Zivadinov R, Pirko I. Advances in understanding gray matter pathology in multiple sclerosis: are we ready to redefine disease pathogenesis? BMC Neurol 2012;12:9.
26. Minagar A, Barnett MH, Benedict RH, et al. The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology 2013;80:210-9.
27. Huitinga I, Erkut ZA, van BD, et al. Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol 2004;55:37-45.
28. Howell OW, Reeves CA, Nicholas R, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011;134:2755-71.
29. Lucchinetti CF, Popescu BF, Bunyan RF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011;365:2188-97.
30. Kutzelnigg A, Faber-Rod JC, Bauer J, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007;17:38-44.
31. Kolasinski J, Stagg CJ, Chance SA, et al. A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology. Brain 2012;135:2938-51.
32. Bermel RA, Fox RJ. MRI in multiple sclerosis. Continuum (Minneap Minn) 2010;16:37-57.
33. Bagnato F, Hametner S, Yao B, et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011;134:3602-15.
34. Lassmann H, van HJ, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol 2012;8:647-56.
35. Zhang X, Haaf M, Todorich B, et al. Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 2005;52:199-208.
36. Khalil M, Teunissen C, Langkammer C. Iron and neurodegeneration in multiple sclerosis. Mult Scler Int 2011;2011:606807.
37. Khalil M, Langkammer C, Ropele S, et al. Determinants of brain iron in multiple sclerosis: a quantitative 3 T MRI study. Neurology 2011;77:1691-7.
38. vanHorssen J, Drexhage JA, Flor T, et al. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions. Free Radic Biol Med 2010;49:1283-9.
39. Mehta V, Pei W, Yang G, et al. Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS ONE 2013;8:e57573.
40. Brown GC. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 2007;35:1119-21.
41. Marburg O. Die sogenannte akute Multiple Sklerose. Jahrbuch Psychiatrie 1906;27:211-312.
42. Spatz H. Über den Eisennachweis im Gehirn, besonders in Zentren des extrapyramidal-motorischen Systems. I. Teil. Zeitschrift für die gesamte. Neurologie und Psychiatrie 1922;77:261-390.
43. Palinski W, Hörkkö S, Miller E, et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996;98:800-14.